Literature DB >> 15921165

Molecular and clinical features of Hb H disease in northern Thailand.

Pimlak Charoenkwan1, Rawee Taweephon, Rattika Sae-Tung, Pattra Thanarattanakorn, Torpong Sanguansermsri.   

Abstract

Clinical assessment, hematological studies and molecular analyses were performed in 102 pediatric patients with Hb H disease in northern Thailand. A total of six mutations of the alpha-globin gene, which produced five genotypes, were detected. All patients had an alpha(0)-thalassemia (thal) deletion on one chromosome 16. All but one of these were of the South East Asian type (--SEA); one patient had the THAI deletion (--THAI). The deletional alpha(+)-thal mutations comprised 3.7 kb (-alpha(3.70) and 4.2 kb (-alpha(4.2)) deletions which were found in 34 (33.3%) and 10 (9.8%) alleles, respectively. The nondeletional alpha(+)-thal mutations comprised 55 (53.9%) alleles of Hb Constant Spring (CS) (alpha142, TAA --> CAA) and three (2.9%) alleles of Hb Pakse (alpha142, TAA --> TAT). Six patients with Hb H-CS disease also carried Hb E (AEBart's CS disease). The clinical features were diverse and the nondeletional genotypes were associated with more severe clinical and hematological features, including younger age at presentation, larger size of liver and spleen, lower hemoglobin (Hb) level, and higher transfusion requirements. The high proportion of nondeletional Hb H disease observed in this study was inconsistent with the previously reported gene frequencies of alpha-thal in the region, suggesting that many deletional Hb H patients with milder symptoms may have escaped recognition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921165

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  5 in total

1.  Molecular characterization of Hb H disease in southern Thailand.

Authors:  Kesara Nittayaboon; Chamnong Nopparatana
Journal:  Int J Hematol       Date:  2018-07-13       Impact factor: 2.490

2.  Molecular characteristics of thalassemia and hemoglobin variants in prenatal diagnosis program in northern Thailand.

Authors:  Kanittha Mankhemthong; Arunee Phusua; Sudjai Suanta; Pitipong Srisittipoj; Pimlak Charoenkwan; Torpong Sanguansermsri
Journal:  Int J Hematol       Date:  2019-06-25       Impact factor: 2.490

3.  Iranian patients with hemoglobin H disease: genotype-phenotype correlation.

Authors:  Mostafa Paridar; Ebrahim Azizi; Bijan Keikhaei; Vahideh Takhviji; Iman Baluchi; Abbas Khosravi
Journal:  Mol Biol Rep       Date:  2019-07-04       Impact factor: 2.316

4.  Clinical features and molecular analysis of Hb H disease in Taiwan.

Authors:  Yu-Hua Chao; Kang-Hsi Wu; Han-Ping Wu; Su-Ching Liu; Ching-Tien Peng; Maw-Sheng Lee
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

5.  The shortcut strategy for beta thalassemia prevention.

Authors:  Narutchala Suwannakhon; Khajohnsilp Pongsawatkul; Teerapat Seeratanachot; Khwanruedee Mahingsa; Arunee Pingyod; Wanwipa Bumrungpakdee; Torpong Sanguansermsri
Journal:  Hematol Rep       Date:  2018-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.